News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genesis Bioventures (GBIW) Announces Name Change to Abviva, Inc.



12/7/2007 11:45:35 AM

LOS ANGELES--(BUSINESS WIRE)--Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) today announced that it has completed its planned name change of the corporation to Abviva, Inc. Genesis Bioventures changed its corporate name to Abviva, Inc. to emphasize its mission to commercialize the Mammastatin Serum Assay (“MSA”) and to pursue development of the mammastatin protein as a possible first line therapy against breast cancer. The name change was approved by the shareholders at the 2007 Annual Shareholders Meeting held on September 14, 2007 as part of the Company’s completion of its reorganization and restructuring plan.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES